Long-term follow-up of thyroid nodule growth

Experimental and Clinical Endocrinology and Diabetes

Volumn 110, Issue 7, 2002, Pages 348-354

  Quadbeck, Beate ^a   Pruellage, J ^a   Roggenbuck, U ^a   Hirche, H ^a   Janssen, O E ^a   Mann, K ^a   Hoermann, R ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Goiter; Levothyroxine; Thyroid nodules; TSH; Ultrasonography

Indexed keywords

LEVOTHYROXINE; THYROTROPIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DISEASE COURSE; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THYROID NODULE; TUMOR GROWTH; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; CELL DIVISION; FOLLOW-UP STUDIES; GOITER; HUMANS; IODIDES; MIDDLE AGED; THYROID FUNCTION TESTS; THYROID GLAND; THYROID NODULE; THYROXINE; TIME FACTORS;

EID: 0036802139     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-34992     Document Type: Article

References (42)

1. Bennedbaek FN, Nielsen LK, Hegedus L. Effect of percutaneous ethanol injection therapy versus suppressive doses of L-thyroxine on benign solitary solid cold thyroid nodules: A randomized trial. J Clin Endocrinol Metabol 1998; 83: 830-835
2. Brix TH, Kyvik KO, Hegedus L. Major role of genes in the etiology of simple goiter in female: A population based twin study. J Clin Endocrinol Metabol 1999; 84: 3071-3075
3. Brunn J, Block U, Bos U, Kunze WP, Scriba PC. Volumetrie der Schilddrüsenlappen mittels Real-Time-Sonographie. Dtsch Med Wochenschrift 1981; 106: 1338-1340
4. Burgi H, Supersaxo Z, Selz B. Iodine deficiency diseases in Switzerland one hundred years after Theodor Kocher's survey: A historical review with some new goitre prevalence data. Acta Endocrinol 1990; 123: 577-590
5. Celani MF, Mariani M, Mariani G. On the usefulness of levothyroxine suppressive therapy in the medical treatment of benign solitary, solid or predominantly solid thyroid nodules. Acta Endocrinol 1990; 123: 603-608
6. Cheung PS, Lee JM, Boey JH. Thyroxine suppressive therapy of benign solitary thyroid nodules: A prospective randomized study. World J Surg 1989; 13: 818-822
7. Csako G, Byrd D, Wesley RA, Sarlis NJ, Skarulis MC, Nieman LK, Pucino F. Assessing the effects of thyroid suppression on benign solitary thyroid nodules. A model for using quantitative research synthesis. Medicine 2000; 79: 9-26
8. Delange F. The disorders induced by iodine deficiency. Thyroid 1994; 4: 107-128 Derwahl
9. M. molekulare aspekte in der pathogenese von knoten und adenomen der schilddrüse. Schweiz Med Wochenschrift 1994; 124: 1613-1618
10. Derwahl M, Broecker M, Kraiem Z. Clinical Review 101: Thyrotropin may not be the dominant growth factor in benign and malignant thyroid tumors. J Clin Endocrinol Metab 1999; 84: 829-834
11. Dunn JT, Medeiros-Neto GA. Endemic Goiter and Cretinism: Continuing Threats to the World Health. Pan American Health Organization, WHO, Scientific Publication No. 2921974;
12. Gharib H, James EM, Charboneau JW, Naessens JM, Offord KP, Gorman CA. Suppressive therapy with levothyroxine for solitary thyroid nodules: A double-blind controlled clinical study. N Engl J Med 1987; 317: 70-75
13. Gharib H. Changing concepts in the diagnosis and management of thyroid nodules. Endocrinol Metab Clin North Am 1997; 26: 777-800
14. Gharib H, Mazzaferri EL. Thyroxine suppressive therapy in patients with nodular thyroid disease. Ann Intern Med 1998; 128: 386-39
15. Gullu S, Gursus MA, Baskal N, Uysal AR, Kamel AN, Erdogan G. Suppressive therapy with levothyroxine for euthyroid diffuse and nodular goiter. Endocr J 1999; 46: 221-226
16. Gutekunst R, Smolarek H, Hasenpusch U, Stubbe P, Friedrich HJ, Wood WG, Scriba PC. Goitre epidemiology: Thyroid volume, iodine excretion, thyroglobulin and thyrotropin in Germany and Sweden. Acta Endocrinol 1986; 112: 494-501
17. Hamburger JI, Miller JM, Kini SR. Diagnosis of thyroid nodules by needle biopsy. In: Ingbar SH, Bravermann LE (eds), Werner's the Thyroid, JB Lippincott Company, Philadelphia 1986; 592-604
18. Hamburger JI, Hamburger SW. Diagnosis and management of large toxic multinodular goiters. J Nucl Med 1985; 26: 888-892
19. Hampel R, Kuhlberg T, Klein K, Jerichow JU, Pichmann EG, Clausen V, Schmidt I. Strumaprävalenz in Deutschland ist größer als bisher angenommen. Med Klinik 1995; 90: 342-349
20. Knudsen N, Bols B, Bulow I, Jorgensen T, Perrild H, Ovesen L, Laurberg P. Validation of ultrasonography of the thyroid gland for epidemiological purposes. Thyroid 1999; 9: 1069-1074
21. Knudsen N, Perrild H, Christiansen E, Rasmussen S, Dige-Petersen H, Jorgensen T. Thyroid structure and size and two-year follow-up of solitary cold thyroid nodules in an unselected population with borderline iodine deficiency. Eur J Endocrinol 2000; 142: 224-230
22. Kopp P, Kimura ET, Aeschimann S, Oestreicher M, Tobler A, Fey MF, Studer H. Polyclonal and monoclonal thyroid nodules coexist within human multinodular goiters. J Clin Endocrinol Metab 1994; 79: 134-139
23. Kuma K, Matsuzuka F, Kobayashi A, Hirai K, Morita S, Miyauchi A, Katayama S, Sugawara M. Outcome of long standing solitary thyroid nodules. World J Surg 1992; 16: 583-588
24. Kuma K, Matsuzuka F, Yokozawa T, Miyauchi A, Sugawara M. Fate of untreated benign thyroid nodules: Results of long-term follow-up. World J Surg 1994; 18: 495-499
25. La Rosa GL, Ippolito AM, Lupo L, Cercabene G, Santonocito MG, Vigneri R, Belfiore A. Cold thyroid nodule reduction with L-thyroxine can be predicted by initial nodule volume and cytological characteristics. J Clin Endocrinol Metab 1996; 81: 4385-4387
26. Lima N, Knobel M, Cavaliere H, Sztejnsznajd C, Tomimori E, Medeiros-Neto G. Levothyroxine suppressive therapy is partially effective in treating patients with benign, solid thyroid nodules and multinodular goiters. Thyroid 1997; 7: 691-697
27. Mainini E, Martinelli I, Morandi G, Villa S, Stefani I, Mazzi C. Levothyroxine suppressive therapy for solitary thyroid nodule. J Endocrinol Invest 1995; 18: 797-799
28. Paggi A, Persegani-Trimarchi C, Russo P, Mastropasqua M, Mosetti MA, Losi T, Leri O. Solitary nodular disease and multinodular goiter: A retrospective study on suppressive versus replacement levothyroxine therapy. Endocr Res 1999; 25: 229-238
29. Papini E, Bacci V, Panunzi C, Pacella CM, Fabbrini R, Bizzarri G, Petrucci L, Giammarco V, La Medica P, Masala M et al. A prospective randomized trial of levothyroxine suppressive therapy for solitary thyroid nodules. Clin Endocrinol 1993; 38: 507-513
30. Papini E, Petrucci L, Guglielmy R, Panunzi C, Rinaldi R, Bacci V, Crescenci A, Nardi F, Fabbrini R, Pacella CM. Long-term changes in nodular goiter: A 5-year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules. J Clin Endocrinol Metab 1998; 83: 780-783
31. Parma J, Duprez L, Van Sande J, Cochaux P, Gervy C, Mockel J, Dumont J, Vassart G. Somatic mutation in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 1993; 365: 649-651
32. Parma J, Duprez L, Van Sande J, Paschke R, Tonacchera M, Dumont J, Vassart G. Constitutively active receptors as a disease-causing mechanism. Mol Cell Endocrinol 1994; 100: 159-162
33. Paschke R, Ludgate M. The thyrotropin receptor in thyroid diseases. N Engl J Med 1997; 337: 1675-1681
34. Peter HJ, Gerber H, Studer H, Smeds S. Pathogenesis of heterogenity in human multinodular goiter. A study on growth and function of thyroid tissue transplantated onto nude mice. J Clin Invest 1985; 76: 1992-2002
35. Reverter JL, Lucas A, Salinas I, Audi L, Foz M, Sanmarti A. Suppressive therapy with levothyroxine for solitary thyroid nodules. Clin Endocrinol 1992; 36: 25-28
36. Scriba PC, Beckers et al. Goitre and iodine deficiency in Europe. Report of the subcommitte for the study of endemic goitre and iodine deficiency of European Thyroid Association. Lancet: 1289-1293, 1985
37. Smeds S, Peter JH, Jortso E, Gerber H, Studer H. Naturally occurring clones of cells with high intrinsic proliferation potential within the follicular epitheelium of mouse thyroids. Cancer Res 1987; 47: 1646-1651
38. Studer H, Peter HJ, Gerber H. Natural heterogeneity of thyroid cells: The basis for understanding thyroid function and nodular goiter growth. Endocr Rev 1989; 10: 125-135
39. Studer H, Derwaht M. Mechanisms of nonneoplastic endocrine hyperplasia - A changing concept: A review focused on the thyroid gland. Endocr Rev 1995; 16: 411-426
40. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, Evans JG, Young E, Bird T, Smith PA. The spectrum of thyroid disease in a community: The Whickham survey. Clin Endocrinol 1977; 7: 481-493
41. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge F et al. The incidence of thyroid disorders in the community: A twenty-year follow-up of the Whickham Survey. Clin Endocrinol 1995; 43: 55-68
42. Zelmanovitz F, Genro S, Gross JL. Suppressive therapy with levothyroxine for solitary thyroid nodules: A double-blind controlled clinical study and cumultative meta-analysis. J Clin Endocrinol Metab 1998; 83: 3881-3885